Treatment-Resistant Depression Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Type (N-methyl-D-aspartate (NMDA), Antidepressants, Antipsychotics, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecasts, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI102820

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Unit	Value (USD billion)
Growth Rate	CAGR of 11.0% from 2023-2030
Segmentation	By Drug Type N-methyl-D-aspartate (NMDA) Antidepressants Antipsychotics Others
	By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies
	By Geography North America (U.S. and Canada) Europe (Germany, U.K., France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, India, Japan, Australia, and the Rest of Asia Pacific) Rest of the World